Illumina Names Aimee Hoyt Chief People Officer, Bringing 20+ Years of Senior Human Resources Leadership from Global Technolog...
December 11 2017 - 9:00AM
Business Wire
Illumina, Inc. (NASDAQ:ILMN) today announced Aimee Hoyt, an
accomplished and strategic talent leader, will head its human
resources team. Ms. Hoyt will join as Senior Vice President
and Chief People Officer (CPO), starting January 8, 2018, and will
be responsible for leading all aspects of the company’s HR
strategies, reporting to the CEO.
This press release features multimedia. View
the full release here:
http://www.businesswire.com/news/home/20171211005352/en/
Aimee Hoyt (Photo: Business Wire)
“After a global search, we are thrilled to have Aimee join
Illumina, and believe she is the right person to help us continue
on our path as an innovative leader in people practices,” said
Francis deSouza, President and Chief Executive Officer
of Illumina. “Adding a CPO of Aimee’s caliber is important to
support Illumina’s continued growth. She has a successful track
record of leading workforce transformation, driving business growth
and creating high-impact teams.”
Ms. Hoyt has held senior positions at some of the world’s
best-known technology companies including Hewlett-Packard, Cisco
and Sun Microsystems. Most recently, she was the Chief Human
Resources Officer at Rackspace, a leading managed cloud computing
company, in San Antonio, Texas. She led the HR team and was
responsible for helping build, align and develop high-performing
global teams. During her tenure, Rackspace was recognized as one of
Fortune’s 100 Best Companies to Work For, Top 30 Best Places in
Tech and Great Places to Work for Millennials. Ms. Hoyt earned a
master’s in human resource development from the Rochester Institute
of Technology.
About Illumina
Illumina is improving human health by unlocking the power
of the genome. Our focus on innovation has established us as the
global leader in DNA sequencing and array-based technologies,
serving customers in the research, clinical, and applied
markets. Our products are used for applications in the life
sciences, oncology, reproductive health, agriculture, and other
emerging segments. To learn more,
visit www.illumina.com and follow @illumina.
Use of forward-looking statements
This release contains forward-looking statements that involve
risks and uncertainties. These forward-looking statements are based
on our expectations as of the date of this release and may differ
materially from actual future events or results. Among the
important factors that could cause actual results to differ
materially from those in any forward-looking statements are (i) our
ability to further develop and commercialize our instruments and
consumables, and to deploy new products, services and applications,
and expand the markets for our technology platforms; (ii) our
ability to manufacture robust instrumentation and consumables;
(iii) our ability to successfully identify and integrate acquired
technologies, products or businesses; (iv) the future conduct and
growth of the business and the markets in which we operate; and (v)
challenges inherent in developing, manufacturing, and launching new
products and services, together with other factors detailed in our
filings with the Securities and Exchange Commission, including
our most recent filings on Forms 10-K and 10-Q, or in information
disclosed in public conference calls, the date and time of which
are released beforehand. We undertake no obligation, and do not
intend, to update these forward-looking statements, to review or
confirm analysts’ expectations, or to provide interim reports or
updates on the progress of the current quarter.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171211005352/en/
Illumina, Inc.Investors:Jacquie Ross,
CFA858-882-2172IR@illumina.comorMedia:Jen
Carroll858-882-6822PR@illumina.com
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Apr 2023 to Apr 2024